MM and Lymphoma
WP study number: |
42206644 |
Working Party: |
CLWP & LWP |
Full Title: |
CALM: Collaboration to collect Autologous transplant outcomes in Lymphoma and Myeloma |
Start Date: |
01 April 2011 |
Key inclusion criteria: |
MM or Lymphoma; >18 years old; auto tx; mobilization including Plerixafor label indication |
Study status: |
ongoing |
Chief Investigator contact: |
Curly Morris
Anna Sureda |
EBMT contact: |
|
Please click on the link below to download the relevant documentation:
Study 42206644
WP study number: |
42206645 |
Working Party: |
CLWP & LWP |
Full Title: |
Plerixafor Off-label Transplant Use |
Start Date: |
01 September 2011 |
Key inclusion criteria: |
One or more of the following:
background disease other than lymphoma or MM; < 18 years old; Tx using ex-vivo plerixafor-mobilised cells; treatment with plerixafor alone; contraindication for G-CSF; allo Tx; Tx using plerixafor-mobilised BM cells; routes of administration other than subcutaneous; cells do not mobilise poorly; other |
Study status: |
ongoing |
Chief Investigator contact: |
Curly Morris
Anna Sureda |
EBMT contact: |
|
Please click on the link below to download the relevant documentation:
Study 42206645
Early complications
WP study number: |
42207728 |
Working Party: |
CLWP |
Full Title: |
Non-interventional prospective study on topical tacrolimus for chronic cutaneous GvHD |
Start Date: |
01 March 2010 |
Key inclusion criteria: |
>18 years old; topical tacrolimus used |
Study status: |
ongoing |
Chief Investigator contact: |
Gregorz Basak |
EBMT contact: |
|
WP study number: |
42207721 |
Working Party: |
CLWP |
Full Title: |
DMSO non-interventional prospective study |
Start Date: |
01 March 2008 |
End date: |
31 January 2010 |
Key inclusion criteria: |
>18years old; CLL, Myeloma or Lymphoma; use of DMSO |
Study status: |
Manuscript phase |
Chief Investigator contact: |
Curly Morris |
EBMT contact: |
|